AUDENTES THERAPEUTICS, INC.
Profile
Company Names
AUDENTES THERAPEUTICS, INC.
Addresses
101 MONTGOMERY STREET, SUITE 2650, SAN FRANCISCO, CA 94104
Phone Numbers
415-638-6556
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$107,499,951.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-10-08
$64,999,949.00
$64,999,949.00
$0.00
Equity
2
2015-08-17
$0.00
INDEFINITE
INDEFINITE
Equity
1
2014-11-21
$42,500,002.00
$42,500,002.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOUIS
LANGE
DIRECTOR
LOUIS
G.
LANGE
DIRECTOR
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
KUSH
PARMAR
DIRECTOR
MATTHEW
PATTERSON
EXECUTIVE OFFICER, DIRECTOR
THOMAS
SCHUETZ
DIRECTOR
JONATHAN
SILVERSTEIN
DIRECTOR
CERAPEDICS INC
| ENOBIA PHARMA CORP
| DFINE INC
| RELYPSA INC
| ROKA BIOSCIENCE, INC.
| ASCENDIS PHARMA A/S
| AUDENTES THERAPEUTICS, INC.
| ADICET BIO, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SCPHARMACEUTICALS INC.
| AVEDRO INC
| NEUROPACE INC
| SPRINGBOX LABS, INC.
| ARCUTIS BIOTHERAPEUTICS, INC.
| SURMOUNT BIO, INC.
| VANQUA BIO, INC.
THOMAS
WOIWODE
DIRECTOR
EURO VENTURES 4, INC.
| AUDENTES THERAPEUTICS, INC.
| KANYOS BIO, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| VIVIDION THERAPEUTICS, INC.
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| LYCIA THERAPEUTICS, INC.
| JENGU THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

